[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Biobeats99 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1687188043390697472.png) @Biobeats99 Luca Research Investment Club

Biotech companies are sharing updates on their research and development progress at various conferences, including ESMO. Several firms, such as Cantor Fitzgerald, Jefferies, and Bank of America, are providing analysis and insights on the biotech sector. Key areas of focus include advancements in cancer treatment, gene therapy, and rare diseases.

### Engagements: XXX [#](/creator/twitter::1687188043390697472/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXXX +55%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX +765%

### Mentions: X [#](/creator/twitter::1687188043390697472/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:posts_active.svg)

- X Week XXX +30%
- X Month XXX +18%
- X Months XXX +133%
- X Year XXX +1,242%

### Followers: XXX [#](/creator/twitter::1687188043390697472/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:followers.svg)

- X Week XXX +0.47%
- X Month XXX +0.94%
- X Months XXX +29%
- X Year XXX +110%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1687188043390697472/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1687188043390697472/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  XX% [stocks](/list/stocks)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXXX% [social networks](/list/social-networks)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$axsm](/topic/$axsm) #5, [$bmrn](/topic/$bmrn) #6, [$ions](/topic/$ions) #4, [$arwr](/topic/$arwr) #8, [$vrtx](/topic/$vrtx) #4, [$alny](/topic/$alny) #2, [$nuvl](/topic/$nuvl) #5, [$cgon](/topic/$cgon) 5%, [$supn](/topic/$supn) #2, [$sage](/topic/$sage) #2

**Top assets mentioned**
[Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Vertex Protocol (VRTX)](/topic/$vrtx) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [CG Oncology, Inc. Common stock (CGON)](/topic/$cgon) [Supernus Pharmaceuticals, Inc. (SUPN)](/topic/$supn) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [Bluefin (BLUE)](/topic/$blue) [Biogen Inc (BIIB)](/topic/$biib) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [BEAM (BEAM)](/topic/$beam) [Taraxa (TARA)](/topic/$tara) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [AbbVie Inc (ABBV)](/topic/$abbv) [Pfizer, Inc. (PFE)](/topic/$pfe) [Amgen, Inc. (AMGN)](/topic/$amgn) [Eli Lilly and Company (LLY)](/topic/$lly) [Johnson & Johnson (JNJ)](/topic/$jnj) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [One Cash (ONC)](/topic/$onc) [Incyte Corporation (INCY)](/topic/$incy) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [uniQure N.V. (QURE)](/topic/$qure) [Goldman Sachs (GS)](/topic/goldman-sachs) [Neenah, Inc. Common Stock (NP)](/topic/$np) [Cheeseball (CB)](/topic/$cb) [Hartford Financial Services Group Inc (HIG)](/topic/$hig) [W R Berkley Corp (WRB)](/topic/$wrb) [Cincinnati Financial Corporation (CINF)](/topic/$cinf) [American Financial Group, Inc. (AFG)](/topic/$afg) [Old Republic International Corporation (ORI)](/topic/$ori) [RenaissanceRe Holdings Ltd. (RNR)](/topic/$rnr) [Everest Re Group Ltd (RE)](/topic/$re) [Everest Group, Ltd. (EG)](/topic/$eg) [RLI Corp. (RLI)](/topic/$rli) [Arch Capital Group Ltd (ACGL)](/topic/$acgl) [Kinsale Capital Group, Inc. (KNSL)](/topic/$knsl) [Selective Insurance Group (SIGI)](/topic/$sigi) [Mercury General Corp. (MCY)](/topic/$mcy) [Neurobro (BRO)](/topic/$bro) [Arthur J. Gallagher & Co. (AJG)](/topic/$ajg) [Willis Towers Watson Public Limited Company Ordinary Shares (WTW)](/topic/$wtw) [Marsh & McLennan Companies, Inc. (MMC)](/topic/$mmc) [S&P Global Inc (SPGI)](/topic/$spgi) [TrustVerse (TRV)](/topic/$trv) [Alliance Fan Token (ALL)](/topic/$all) [Progressive Corp (PGR)](/topic/$pgr) [American International Group Inc (AIG)](/topic/$aig) [Markel, Corp. (MKL)](/topic/$mkl) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Vaxcyte, Inc. Common Stock (PCVX)](/topic/$pcvx) [SuperRare (RARE)](/topic/$rare) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Bank of America (BAC)](/topic/bank-of-america) [Immunogen Inc (IMGN)](/topic/$imgn)
### Top Social Posts
Top posts by engagements in the last XX hours

"RBC SUPN US: Supernus Pharmaceuticals Initial Opinion Firing on all cylinders with trifecta of branded CNS launches: Initiate Buy $XX PO Full report in bio $SUPN $AXSM $RLMD $SAGE $CYT $LLY $BMY $BIIB $ABBV $JNJ $PFE $AMGN $VRTX $BMRN $SRPT $IONS $ALNY $ARWR $BLUE"  
[X Link](https://x.com/Biobeats99/status/1989479072125288901)  2025-11-14T23:42Z XXX followers, XXX engagements


"Jefferies Praxis Precision Medicines reports two positive clinical developments: one in Essential Tremor and another in a rare form of epilepsy reinforcing its pipeline's potential. BUY rating maintained. Full report in Bio $PRAX $AXSM $SAGE $SEEL $BIIB $NBIX $ACAD $SUPN"  
[X Link](https://x.com/Biobeats99/status/1996815026435620875)  2025-12-05T05:32Z XXX followers, XXX engagements


"U.S. Small & Mid Cap Biotechnology: Key Takeaways from KOL Call on Heme Malignancies: Read-through for Nurix (NRIX) BeOne (ONC) and Incyte (INCY) Full report in Telegram (in bio)👆 $NRIX $ONC $INCY $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE"  
[X Link](https://x.com/Biobeats99/status/1979055787205890525)  2025-10-17T05:24Z XXX followers, XXX engagements


"Goldman Sachs Neptune Holdings: A Flood Insurance Leader with a Unique Market Growth + Market Share Gains Story; Initiate Buy Full report in bio $NP $TRV $CB $ALL $PGR $HIG $AIG $WRB $CINF $AFG $ORI $RNR $RE $EG $MKL $RLI $ACGL $KNSL $SIGI $MCY $BRO $AJG $WTW $MMC $SPGI"  
[X Link](https://x.com/Biobeats99/status/1985481633802437043)  2025-11-03T22:58Z XXX followers, XXX engagements


"Jefferies Monthly digest of the firm's most-read research reports and the top questions from institutional investors (the buyside) for November 2025 highlighting key sector trends and focal points. Full report in Bio $NUVL $ZYME $AGIO $VKTX $PCVX $TARA $CGON $AXSM $SVRA"  
[X Link](https://x.com/Biobeats99/status/1995526471092142406)  2025-12-01T16:12Z XXX followers, XXX engagements


"Jefferies BioMarin Pharmaceutical: The PDUFA delay for ASND is viewed as a procedural rather than clinical issue with limited fundamental impact. BUY rating maintained with confidence in the program's approval prospects in 1H26. Full report in Bio $BMRN $RARE $BGNE $UTHR"  
[X Link](https://x.com/Biobeats99/status/1994112833575858440)  2025-11-27T18:35Z XXX followers, XXX engagements


"Bank of America Janux Therapeutics' price objective has been adjusted. The report frames the near-term catalyst for JANX007 as a binary outcome posing the question of which type of news investors should prepare for first. Full report in Bio $JANX $KYMR $CGON $IMGN $RXRX $DYN"  
[X Link](https://x.com/Biobeats99/status/1995882090861322476)  2025-12-02T15:45Z XXX followers, XXX engagements


"Jefferies Crescent's strategic partnership with Kelun represents a major step forward providing validation resources and potential acceleration for its clinical pipeline. Full report in Bio $CBIO $RXRX $KYMR $DYN $CGON $TARA $ACRV $SVRA $PRAX $AXSM $NUVL $BEAM $NTLA"  
[X Link](https://x.com/Biobeats99/status/1996814600625705361)  2025-12-05T05:31Z XXX followers, XXX engagements


"Cantor Fitzgerald Analysis of Arrowhead's pooled baseline data from its Phase X SHTG trial indicates a well-characterized patient population reducing clinical risk ahead of topline results. Positive stock outlook maintained. Full report in Bio $ARWR $ALNY $IONS $VRTX $NUVL"  
[X Link](https://x.com/Biobeats99/status/1996815371727458668)  2025-12-05T05:34Z XXX followers, XXX engagements